Clinical Trial

Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
A Study of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) Therapy for Patients With Advanced Solid Tumors
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-30.
Status change: Not Yet Recruiting → Recruiting 2025-09-09
Trial Details
NCT Number NCT07106814
Lead Sponsor Anhui Provincial Hospital
Collaborators: Leman Biotech Co., Ltd.
Conditions Advanced Solid Tumors
Enrollment 36 participants
Start Date 2025-08-29
Primary Completion 2027-08-15 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-15